{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:06:18Z","timestamp":1792739178400,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.numecd.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:33:28Z","timestamp":1694234008000},"page":"251-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-1159","authenticated-orcid":false,"given":"Zhouli","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-3194","authenticated-orcid":false,"given":"Ljupcho","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1271-7204","authenticated-orcid":false,"given":"Rafael","family":"Mikolajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.numecd.2023.09.002_bib1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors","volume":"289","author":"Mokdad","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-013-9252-x","article-title":"Metabolically healthy obesity: definitions, determinants and clinical implications","volume":"14","author":"Phillips","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOL.0b013e3283346ccc","article-title":"The distinction of metabolically \u2018healthy\u2019from \u2018unhealthy\u2019obese individuals","volume":"21","author":"Bl\u00fcher","year":"2010","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib5","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kl\u00f6ting","year":"2010","journal-title":"Am J Physiol Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2009.06.020","article-title":"Metabolically healthy but obese individuals: relationship with hepatic enzymes","volume":"59","author":"Messier","year":"2010","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2023.09.002_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.numecd.2023.09.002_bib9","first-page":"2013","article-title":"Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome","author":"Fuentes","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib10","doi-asserted-by":"crossref","first-page":"461S","DOI":"10.1093\/ajcn\/83.2.461S","article-title":"Obesity and the role of adipose tissue in inflammation and metabolism","volume":"83","author":"Greenberg","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib11","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2023.09.002_bib13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.numecd.2022.06.010","article-title":"Transition from metabolically healthy to unhealthy overweight\/obesity and risk of cardiovascular disease incidence: a systematic review and meta-analysis","volume":"32","author":"Abiri","year":"2022","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.09.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111590","article-title":"Metabolically unhealthy and overweight phenotypes are associated with increased levels of inflammatory cytokines: a population-based study","volume":"96","author":"Ferreira","year":"2022","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.numecd.2023.09.002_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2362.2008.01962.x","article-title":"Inflammatory markers in relation to insulin resistance and the metabolic syndrome","volume":"38","author":"Ingelsson","year":"2008","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.ejcn.1602384","article-title":"Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin","volume":"60","author":"Gonz\u00e1lez","year":"2006","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/met.2013.0102","article-title":"Metabolically healthy obesity and its associates in Mongolian Chinese adults","volume":"12","author":"Zhang","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.numecd.2023.09.002_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9294038","article-title":"Characterization of metabolically healthy obese people and metabolically unhealthy normal-weight people in a general population cohort of the ABCD study","volume":"2017","author":"Buscemi","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.numecd.2023.09.002_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cyto.2017.12.008","article-title":"Myostatin and adipokines: the role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults","volume":"107","author":"Carvalho","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.numecd.2023.09.002_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.autneu.2018.05.008","article-title":"Metabolic syndrome impact on cardiac autonomic modulation and exercise capacity in obese adults","volume":"213","author":"Carvalho","year":"2018","journal-title":"Auton Neurosci"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3803\/EnM.2015.30.2.185","article-title":"Comparison of serum adipocytokine levels according to metabolic health and obesity status","volume":"30","author":"Lee","year":"2015","journal-title":"Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2023.09.002_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/178526","article-title":"Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population","volume":"2015","author":"Shaharyar","year":"2015","journal-title":"J obes"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib24","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.orcp.2011.04.003","article-title":"Dysmetabolic signals in \u201cmetabolically healthy\u201d obesity","volume":"6","author":"Manu","year":"2012","journal-title":"Obes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1751-7176.2009.00238.x","article-title":"Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus","volume":"12","author":"Mojiminiyi","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4082\/kjfm.2013.34.1.19","article-title":"Comparison of metabolic characteristics of metabolically healthy but obese (MHO) middle-aged men according to different criteria","volume":"34","author":"Yoo","year":"2013","journal-title":"Korean J fam med"},{"key":"10.1016\/j.numecd.2023.09.002_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjcard.2014.11.036","article-title":"Vascular inflammation in metabolically abnormal but normal-weight and metabolically healthy obese individuals analyzed with 18F-fluorodeoxyglucose positron emission tomography","volume":"115","author":"Yoo","year":"2015","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.numecd.2023.09.002_bib29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/ijo.2017.147","article-title":"Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals","volume":"41","author":"Ba\u00f1uls","year":"2017","journal-title":"Int J Obes"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib30","article-title":"Subclinical risk markers for cardiovascular disease (CVD) in metabolically healthy obese (MHO) subjects","volume":"13","author":"Acharya","year":"2019","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s42000-020-00201-1","article-title":"The regulation of serum resistin levels in metabolically healthy and unhealthy obese individuals","volume":"19","author":"Christou","year":"2020","journal-title":"Hormones"},{"key":"10.1016\/j.numecd.2023.09.002_bib32","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2147\/DMSO.S263727","article-title":"Metabolically healthy, but obese individuals and associations with echocardiographic parameters and inflammatory biomarkers: results from the CARLA Study","volume":"13","author":"Efremov","year":"2020","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diabet.2014.02.007","article-title":"Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects","volume":"40","author":"Esteghamati","year":"2014","journal-title":"Diabetes Metabol"},{"key":"10.1016\/j.numecd.2023.09.002_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.maturitas.2016.08.008","article-title":"The associations between physical fitness and cardiometabolic risk and body-size phenotypes in perimenopausal women","volume":"92","author":"Gregorio-Arenas","year":"2016","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3325\/cmj.2017.58.106","article-title":"Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidase","volume":"58","author":"Koborov\u00e1","year":"2017","journal-title":"Croat Med J"},{"issue":"9","key":"10.1016\/j.numecd.2023.09.002_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106641","article-title":"Profile of individuals who are metabolically healthy obese using different definition criteria. A population-based analysis in the Spanish population","volume":"9","author":"Mart\u00ednez-Larrad","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/diagnostics11010040","article-title":"Visceral adiposity, pro-inflammatory signaling and vasculopathy in metabolically unhealthy non-obesity phenotype","volume":"11","author":"Tsou","year":"2021","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190528","article-title":"Metabolically healthy obese individuals present similar chronic inflammation level but less insulin-resistance than obese individuals with metabolic syndrome","volume":"12","author":"Iglesias Molli","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088539","article-title":"A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals","volume":"9","author":"Perreault","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-6-121","article-title":"The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: the Brazilian study on healthy aging","volume":"6","author":"Roberson","year":"2014","journal-title":"Diabetol Metab Syndrome"},{"issue":"10","key":"10.1016\/j.numecd.2023.09.002_bib41","doi-asserted-by":"crossref","first-page":"E1610","DOI":"10.1210\/jc.2013-2038","article-title":"Does inflammation determine metabolic health status in obese and nonobese adults?","volume":"98","author":"Phillips","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"issue":"9","key":"10.1016\/j.numecd.2023.09.002_bib42","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3390\/nu11091976","article-title":"No difference in lactoferrin levels between metabolically healthy and unhealthy obese women","volume":"11","author":"Jamka","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-017-0298-x","article-title":"Favourable metabolic profile sustains mitophagy and prevents metabolic abnormalities in metabolically healthy obese individuals","volume":"9","author":"Bhansali","year":"2017","journal-title":"Diabetol Metab Syndrome"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib44","first-page":"509","article-title":"Comparative study of inflammatory and oxidative stress biomarkers in different metabolically healthy obesity phenotypes","volume":"11","author":"Dwivedi","year":"2020","journal-title":"Food Nutr Sci"},{"issue":"11","key":"10.1016\/j.numecd.2023.09.002_bib45","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00125-013-3023-9","article-title":"Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue","volume":"56","author":"Esser","year":"2013","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/oby.21768","article-title":"Metabolically healthy obesity and incident chronic kidney disease: the role of systemic inflammation in a prospective study","volume":"25","author":"Lin","year":"2017","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jc.2014-3885","article-title":"The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation","volume":"100","author":"Jung","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-11-754","article-title":"Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey","volume":"11","author":"Pajunen","year":"2011","journal-title":"BMC Publ Health"},{"issue":"7","key":"10.1016\/j.numecd.2023.09.002_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.14260\/jemds\/2020\/100","article-title":"High-sensitivity C-reactive protein in metabolic healthy obesity (MHO)","volume":"9","author":"Rasheed","year":"2020","journal-title":"J Evol Med Dental Sci-JEMDS"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib50","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4162\/nrp.2019.13.6.488","article-title":"Differences in dietary intakes, body compositions, and biochemical indices between metabolically healthy and metabolically abnormal obese Korean women","volume":"13","author":"Kang","year":"2019","journal-title":"Nutr Res Prac"},{"issue":"10","key":"10.1016\/j.numecd.2023.09.002_bib51","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.ijo.0803304","article-title":"Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women","volume":"30","author":"Shin","year":"2006","journal-title":"Int J Obes"},{"issue":"11","key":"10.1016\/j.numecd.2023.09.002_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14727","article-title":"The missing link between inflammation and arterial stiffness among different metabolic phenotypes","volume":"75","author":"G\u00f6k\u00e7ay Canpolat","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/nu14020373","article-title":"Application of a machine learning Technology in the Definition of metabolically healthy and unhealthy status: a retrospective study of 2567 subjects suffering from obesity with or without metabolic syndrome","volume":"14","author":"Masi","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib54","article-title":"Comparison of epicardial fat thickness between metabolically healthy and unhealthy obese women","volume":"49","author":"Demirci","year":"2021","journal-title":"Turk Kardiyol Dernegi Arsivi"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib55","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1210\/clinem\/dgab061","article-title":"In men with obesity, T2DM is associated with poor trabecular microarchitecture and bone strength and low bone turnover","volume":"106","author":"Vigevano","year":"2021","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2023.09.002_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.792795","article-title":"Serum bilirubin level is increased in metabolically healthy obesity","volume":"12","author":"Fu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/nu14050915","article-title":"Metabolically healthy and unhealthy obese phenotypes among Arabs and South Asians: prevalence and relationship with cardiometabolic indicators","volume":"14","author":"Oguoma","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.numecd.2023.09.002_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11652","article-title":"Clinical characteristics and classification of Cameroonians with obesity and metabolically normal phenotype in the West region of Cameroon","volume":"8","author":"Nguedjo","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.numecd.2023.09.002_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.127462","article-title":"Short-term ozone exposure and metabolic status in metabolically healthy obese and normal-weight young adults: a viewpoint of inflammatory pathways","volume":"424","author":"Wang","year":"2022","journal-title":"J Hazard Mater"},{"issue":"11","key":"10.1016\/j.numecd.2023.09.002_bib60","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1210\/jc.2015-2765","article-title":"Adiponectin levels differentiate metabolically healthy vs unhealthy among obese and nonobese white individuals","volume":"100","author":"Ahl","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib61","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1021\/acs.jproteome.7b00802","article-title":"Obesity-related metabolomic profiles and discrimination of metabolically unhealthy obesity","volume":"17","author":"Bagheri","year":"2018","journal-title":"J Proteome Res"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib62","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/nu8120759","article-title":"Disability, physical inactivity, and impaired health-related quality of life are not different in metabolically healthy vs. unhealthy obese subjects","volume":"8","author":"Donini","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2023.09.002_bib63","first-page":"19","article-title":"Are young Iranian women with metabolically healthy obesity at increased risk of CVD incidence?","author":"Hosseini","year":"2020","journal-title":"J Vas Brasileiro"},{"key":"10.1016\/j.numecd.2023.09.002_bib64","series-title":"Mayo clinic proceedings","article-title":"Are metabolically healthy overweight\/obese men at increased risk of sudden cardiac death?","author":"Jae","year":"2018"},{"key":"10.1016\/j.numecd.2023.09.002_bib65","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3389\/fimmu.2017.01700","article-title":"Natural killer cell activity and interleukin-12 in metabolically healthy versus metabolically unhealthy overweight individuals","volume":"8","author":"Kim","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.numecd.2023.09.002_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.metabol.2019.01.003","article-title":"Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study","volume":"93","author":"Kouvari","year":"2019","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/diagnostics11030408","article-title":"Diverse adiposity and atrio-ventricular dysfunction across obesity phenotypes: implication of epicardial fat analysis","volume":"11","author":"Lai","year":"2021","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/eurheartj\/ehx448","article-title":"Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis","volume":"39","author":"Lassale","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/met.2017.0078","article-title":"Interaction of metabolic health and obesity on subclinical target organ damage","volume":"16","author":"Lee","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib70","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/life11121350","article-title":"Association of metabolically healthy and unhealthy obesity phenotype with markers related to obesity, diabetes among young, healthy adult men. analysis of MAGNETIC study","volume":"11","author":"Lejawa","year":"2021","journal-title":"Life"},{"issue":"7","key":"10.1016\/j.numecd.2023.09.002_bib71","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/nu8070432","article-title":"Metabolically healthy overweight and obesity is associated with higher adherence to a traditional dietary pattern: a cross-sectional study among adults in Lebanon","volume":"8","author":"Matta","year":"2016","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174945","article-title":"Metabolically healthy obese women have longer telomere length than obese women with metabolic syndrome","volume":"12","author":"Iglesias Molli","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.numecd.2023.09.002_bib73","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/oby.20200","article-title":"Ectopic fat and adipokines in metabolically benign overweight\/obese women: the Kronos Early Estrogen Prevention Study","volume":"21","author":"Ogorodnikova","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.numecd.2023.09.002_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2021.10.002","article-title":"Vitamin D is directly associated with favorable glycemic, lipid, and inflammatory profiles in individuals with at least one component of metabolic syndrome irrespective of total adiposity: pr\u00f3-Sa\u00fade Study, Brazil","volume":"96","author":"Oliveira","year":"2021","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib75","doi-asserted-by":"crossref","DOI":"10.15275\/rusomj.2020.0301","article-title":"Metabolically healthy obesity: prevalence, phenotype characteristic, effectiveness of weight loss","volume":"9","author":"Ostrovskaya","year":"2020","journal-title":"Russ Open Med J"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib76","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.clnu.2019.01.028","article-title":"The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity","volume":"38","author":"Poggiogalle","year":"2019","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib77","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.numecd.2020.02.012","article-title":"Impact of metabolically healthy obesity on carotid intima-media thickness-The Brazilian Longitudinal Study of Adult Health","volume":"30","author":"Romagnolli","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000345026","article-title":"A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women","volume":"62","author":"Ruiz","year":"2013","journal-title":"Ann Nutr Metabol"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5551\/jat.10918","article-title":"Mannose-binding lectin in obesity with different degrees of metabolic syndrome abnormalities: association with atherogenic and metabolic traits","volume":"19","author":"Strack","year":"2012","journal-title":"J Atherosclerosis Thromb"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjms.2016.06.017","article-title":"Metabolically obese individuals of normal weight have a high risk of 25-hydroxyvitamin D deficiency","volume":"352","author":"Wang","year":"2016","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib81","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0300060516663778","article-title":"Peripheral invariant natural killer T cell deficiency in metabolically unhealthy but normal weight versus metabolically healthy but obese individuals","volume":"44","author":"Wang","year":"2016","journal-title":"J Int Med Res"},{"key":"10.1016\/j.numecd.2023.09.002_bib82","first-page":"263","article-title":"Metabolically healthy obesity is associated with longitudinal changes in high-density lipoprotein cholesterol in Chinese adults. Eating and Weight Disorders-Studies on Anorexia","volume":"26","author":"Yang","year":"2021","journal-title":"Bulimia Obesity"},{"issue":"11","key":"10.1016\/j.numecd.2023.09.002_bib83","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.metabol.2016.08.002","article-title":"Clinical implication of body size phenotype on heart rate variability","volume":"65","author":"Yoo","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2023.09.002_bib84","article-title":"Transition of metabolic phenotypes and risk of atrial fibrillation according to BMI: Kailuan study","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.numecd.2023.09.002_bib85","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/oby.22950","article-title":"Metabolic health status contributes to transcriptome alternation in human visceral adipose tissue during obesity","volume":"28","author":"Zhou","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.numecd.2023.09.002_bib86","series-title":"Association metabolic obesity phenotypes with cardiometabolic index, atherogenic index of plasma and novel anthropometric indices: a link of FTO-rs9939609 polymorphism","first-page":"249","author":"Abolnezhadian","year":"2020"},{"key":"10.1016\/j.numecd.2023.09.002_bib87","series-title":"Circulating apoptotic endothelial cell-derived microparticles are predicted metabolically unhealthy obesity","author":"Berezin","year":"2017"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7570\/jomes19078","article-title":"Beta-cell function, self-rated health, and lifestyle habits in 64-year-old Swedish women with metabolically healthy obesity phenotype","volume":"29","author":"Hjelmgren","year":"2020","journal-title":"J Obesity Metabolic Syndrome"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cen.13074","article-title":"The association of incident hypertension with metabolic health and obesity status: definition of metabolic health does not matter","volume":"85","author":"Kang","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib90","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jc.2012-3292","article-title":"Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS)","volume":"98","author":"Kim","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib91","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1002\/oby.20061","article-title":"Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults","volume":"21","author":"Mangge","year":"2013","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.numecd.2023.09.002_bib92","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/HJH.0b013e32834a50f3","article-title":"Obesity phenotype and cardiovascular changes","volume":"29","author":"Park","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2023.09.002_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2023.06.002","article-title":"Transitions in metabolic health and onset age of cardiovascular diseases","author":"Zhao","year":"2023","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib94","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-18-0356","article-title":"Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study","volume":"179","author":"Xu","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/antiox10010093","article-title":"Association of metabolically healthy and unhealthy obesity phenotypes with oxidative stress parameters and telomere length in healthy young adult men. Analysis of the magnetic study","volume":"10","author":"Lejawa","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.numecd.2023.09.002_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7918714","article-title":"Relationship of circulating fetuin-A levels with body size and metabolic phenotypes","volume":"2018","author":"Chung","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib97","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/nu10040447","article-title":"Waist circumference is an anthropometric parameter that identifies women with metabolically unhealthy phenotypes","volume":"10","author":"Torres-Castillo","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13813455.2018.1434207","article-title":"New lower cutoff for serum high sensitive C-reactive protein in obese women indicates the risk of metabolic syndrome","volume":"125","author":"Kucharska","year":"2019","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib99","first-page":"37","article-title":"Serum concentrations of cholecystokinin, peptide YY, ghrelin and high sensitive C-reactive protein in association with metabolic syndrome ingredients in obese individuals","volume":"16","author":"Mesgari-Abbasi","year":"2020","journal-title":"Acta Endocrinol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamainternmed.2013.10522","article-title":"Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome","volume":"174","author":"Thomsen","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2014.02.033","article-title":"Association of metabolically abnormal but normal weight (MANW) and metabolically healthy but obese (MHO) individuals with arterial stiffness and carotid atherosclerosis","volume":"234","author":"Yoo","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/oby.22377","article-title":"Metabolically healthy obesity and risk for atrial fibrillation: the HUNT study","volume":"27","author":"Feng","year":"2019","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/HJH.0b013e32835a3637","article-title":"Obesity phenotype and incident hypertension: a prospective community-based cohort study","volume":"31","author":"Lee","year":"2013","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib104","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ki.2015.183","article-title":"The risk of chronic kidney disease in a metabolically healthy obese population","volume":"88","author":"Jung","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2023.09.002_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154893","article-title":"The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: a population-based cohort study","volume":"128","author":"Kouvari","year":"2022","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib106","doi-asserted-by":"crossref","DOI":"10.2196\/33026","article-title":"A bayesian network analysis of the probabilistic relationships between various obesity phenotypes and cardiovascular disease risk in Chinese adults: Chinese population-based observational study","volume":"10","author":"Tian","year":"2022","journal-title":"JMIR Medical Informatics"},{"key":"10.1016\/j.numecd.2023.09.002_bib107","series-title":"Change in metabolic health status over time and risk of chronic kidney disease: a prospective study","author":"Cui","year":"2022"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib108","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/Obesities1010006","article-title":"Postprandial triglycerides, flow-mediated dilation, and the inflammatory cytokine milieu in metabolically healthy obesity: a cross-sectional pilot study","volume":"1","author":"Keirns","year":"2021","journal-title":"Obesities"},{"issue":"7","key":"10.1016\/j.numecd.2023.09.002_bib109","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.metabol.2013.01.006","article-title":"Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease","volume":"62","author":"Kwon","year":"2013","journal-title":"Metabolism"},{"issue":"19","key":"10.1016\/j.numecd.2023.09.002_bib110","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on detection, E., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"Jama"},{"issue":"9491","key":"10.1016\/j.numecd.2023.09.002_bib111","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.numecd.2023.09.002_bib112","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.numecd.2023.09.002_bib113","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib114","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.ATV.19.4.972","article-title":"C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?","volume":"19","author":"Yudkin","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc12-0702","article-title":"Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.09.002_bib116","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2016.06.028","article-title":"Adiponectin, TNF-\u03b1 and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"86","author":"Liu","year":"2016","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/HJH.0b013e3283324650","article-title":"Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China","volume":"28","author":"Zhang","year":"2010","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2003.08.016","article-title":"C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report","volume":"97","author":"Lee","year":"2004","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib119","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.0000136581.59584.0E","article-title":"C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study","volume":"110","author":"Rutter","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib121","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2003-031005","article-title":"Adipocytokines and insulin resistance","volume":"89","author":"Pittas","year":"2004","journal-title":"J Clin Endocrinol Metabol"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib122","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.numecd.2023.09.002_bib123","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0165-6147(03)00132-9","article-title":"Do regional differences in adipocyte biology provide new pathophysiological insights?","volume":"24","author":"Lafontan","year":"2003","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.numecd.2023.09.002_bib124","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2337\/diabetes.51.7.2029","article-title":"Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes","volume":"51","author":"van Harmelen","year":"2002","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/oby.2010.22","article-title":"The human visceral fat depot has a unique inflammatory profile","volume":"18","author":"Alvehus","year":"2010","journal-title":"Obesity"},{"issue":"10","key":"10.1016\/j.numecd.2023.09.002_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003351","article-title":"Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: a cohort study","volume":"17","author":"Gao","year":"2020","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib127","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2337\/diacare.28.4.878","article-title":"The metabolic syndrome and concentrations of C-reactive protein among US youth","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib128","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.CIR.0000055188.83694.B3","article-title":"Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue","volume":"107","author":"Ouchi","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib129","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.M700535-JLR200","article-title":"Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats","volume":"49","author":"Singh","year":"2008","journal-title":"J Lipid Res"},{"issue":"22","key":"10.1016\/j.numecd.2023.09.002_bib130","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1001\/jama.290.22.2945","article-title":"C-reactive protein and the risk of developing hypertension","volume":"290","author":"Sesso","year":"2003","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.numecd.2023.09.002_bib131","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-\u03baB\u2014a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib132","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2008.05.060","article-title":"C-reactive protein stimulates superoxide anion release and tissue factor activity in\u00a0vivo","volume":"203","author":"Devaraj","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2023.09.002_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.numecd.2023.09.002_bib134","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc12-1654","article-title":"Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?","volume":"36","author":"Hinnouho","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/joim.13082","article-title":"Ethnic differences in adiposity and diabetes risk\u2013insights from genetic studies","volume":"288","author":"Yaghootkar","year":"2020","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.numecd.2023.09.002_bib136","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3803\/EnM.2020.772","article-title":"Genetic and environmental factors contributing to visceral adiposity in Asian populations","volume":"35","author":"Williams","year":"2020","journal-title":"Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","article-title":"Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT)","volume":"86","author":"Lear","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.numecd.2023.09.002_bib138","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/jcem.86.3.7305","article-title":"Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women","volume":"86","author":"Fernandez-Real","year":"2001","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib139","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-neuro-endocrine interactions: facts and hypotheses","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.numecd.2023.09.002_bib140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-2952(93)90393-B","article-title":"Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen","volume":"45","author":"Masaoki","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.numecd.2023.09.002_bib141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0083-6729(08)00621-3","article-title":"Interleukin-6 and insulin resistance","volume":"80","author":"Kim","year":"2009","journal-title":"Vitam Horm"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib142","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1210\/me.2005-0490","article-title":"Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle","volume":"20","author":"Al-Khalili","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib143","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of interleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.numecd.2023.09.002_bib144","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.metabol.2004.02.007","article-title":"Serum tumor necrosis factor-\u03b1 levels and components of the metabolic syndrome in obese adolescents","volume":"53","author":"Moon","year":"2004","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.numecd.2023.09.002_bib145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/ENDO:23:2-3:177","article-title":"The role of TNF-\u03b1 in insulin resistance","volume":"23","author":"Borst","year":"2004","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.numecd.2023.09.002_bib146","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.numecd.2023.09.002_bib147","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1073\/pnas.96.12.6902","article-title":"Tumor necrosis factor \u03b1 is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1","volume":"96","author":"Samad","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.numecd.2023.09.002_bib148","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/diab.46.9.1526","article-title":"Targeted disruption of the tumor necrosis factor-\u03b1 gene: metabolic consequences in obese and nonobese mice","volume":"46","author":"Ventre","year":"1997","journal-title":"Diabetes"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323003484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323003484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T23:36:29Z","timestamp":1746747389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0939475323003484"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.09.002","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}